GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Acro Biomedical Co Ltd (OTCPK:ACBM) » Definitions » Price-to-Owner-Earnings

Acro Biomedical Co (Acro Biomedical Co) Price-to-Owner-Earnings : (As of Jun. 09, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Acro Biomedical Co Price-to-Owner-Earnings?

As of today (2024-06-09), Acro Biomedical Co's share price is $0.105. Acro Biomedical Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Acro Biomedical Co's Price-to-Owner-Earnings or its related term are showing as below:


ACBM's Price-to-Owner-Earnings is not ranked *
in the Medical Distribution industry.
Industry Median: 12.27
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-09), Acro Biomedical Co's share price is $0.105. Acro Biomedical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.25. Therefore, Acro Biomedical Co's PE Ratio for today is At Loss.

As of today (2024-06-09), Acro Biomedical Co's share price is $0.105. Acro Biomedical Co's EPS without NRI for the trailing twelve months (TTM) ended in was $-0.25. Therefore, Acro Biomedical Co's PE Ratio without NRI for today is At Loss.

During the past 8 years, Acro Biomedical Co's highest PE Ratio without NRI was 4890.00. The lowest was 0.00. And the median was 740.00.


Acro Biomedical Co Price-to-Owner-Earnings Historical Data

The historical data trend for Acro Biomedical Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acro Biomedical Co Price-to-Owner-Earnings Chart

Acro Biomedical Co Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Dec20 Dec21 Dec22
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

Acro Biomedical Co Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Acro Biomedical Co's Price-to-Owner-Earnings

For the Medical Distribution subindustry, Acro Biomedical Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acro Biomedical Co's Price-to-Owner-Earnings Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Acro Biomedical Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Acro Biomedical Co's Price-to-Owner-Earnings falls into.



Acro Biomedical Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Acro Biomedical Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.105/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acro Biomedical Co  (OTCPK:ACBM) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Acro Biomedical Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Acro Biomedical Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Acro Biomedical Co (Acro Biomedical Co) Business Description

Traded in Other Exchanges
N/A
Address
12175 Visionary Way, Suite 1160, Fishers, IN, USA, 46038
Acro Biomedical Co Ltd develops and manufactures nutritional products. The company offers cordyceps fungus for medicinal purposes. It also sells cordycepin and cordyceps powder.
Executives
Pao-chi Chu director, 10 percent owner, officer: CEO 2F, NO. 356 SEC 1. DUNHUA S. RD., DA'AN DISTRICT, TAIPEI CITY F5 106

Acro Biomedical Co (Acro Biomedical Co) Headlines

No Headlines